GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Claritev Corp (NYSE:CTEV) » Definitions » Asset Turnover

CTEV (Claritev) Asset Turnover : 0.04 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Claritev Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Claritev's Revenue for the three months ended in Dec. 2024 was $232.1 Mil. Claritev's Total Assets for the quarter that ended in Dec. 2024 was $5,235.0 Mil. Therefore, Claritev's Asset Turnover for the quarter that ended in Dec. 2024 was 0.04.

Asset Turnover is linked to ROE % through Du Pont Formula. Claritev's annualized ROE % for the quarter that ended in Dec. 2024 was -378.53%. It is also linked to ROA % through Du Pont Formula. Claritev's annualized ROA % for the quarter that ended in Dec. 2024 was -10.54%.


Claritev Asset Turnover Historical Data

The historical data trend for Claritev's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Claritev Asset Turnover Chart

Claritev Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Turnover
Get a 7-Day Free Trial 0.11 0.14 0.14 0.13 0.15

Claritev Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.04 0.04

Competitive Comparison of Claritev's Asset Turnover

For the Health Information Services subindustry, Claritev's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Claritev's Asset Turnover Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Claritev's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Claritev's Asset Turnover falls into.


;
;

Claritev Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Claritev's Asset Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=930.624/( (6964.687+5150.827)/ 2 )
=930.624/6057.757
=0.15

Claritev's Asset Turnover for the quarter that ended in Dec. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=232.145/( (5319.204+5150.827)/ 2 )
=232.145/5235.0155
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Claritev  (NYSE:CTEV) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Claritev's annulized ROE % for the quarter that ended in Dec. 2024 is

ROE %**(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-551.86/145.792
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-551.86 / 928.58)*(928.58 / 5235.0155)*(5235.0155/ 145.792)
=Net Margin %*Asset Turnover*Equity Multiplier
=-59.43 %*0.1774*35.9074
=ROA %*Equity Multiplier
=-10.54 %*35.9074
=-378.53 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Claritev's annulized ROA % for the quarter that ended in Dec. 2024 is

ROA %(Q: Dec. 2024 )
=Net Income/Total Assets
=-551.86/5235.0155
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-551.86 / 928.58)*(928.58 / 5235.0155)
=Net Margin %*Asset Turnover
=-59.43 %*0.1774
=-10.54 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) net income data. The Revenue data used here is four times the quarterly (Dec. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Claritev Asset Turnover Related Terms

Thank you for viewing the detailed overview of Claritev's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Claritev Business Description

Traded in Other Exchanges
N/A
Address
7900 Tysons One Place, Suite 400, McLean, VA, USA, 22102
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Executives
Michael Kim officer: See Remarks POLARIS PARENT CORP, 115 FIFTH AVENUE, NEW YORK NY 10003
Anthony Jr Colaluca director MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
John Michael Prince director 115 FIFTH AVE., NEW YORK NY 10003
Nutter Carol officer: SVP, Chief People Officer 115 FIFTH AVE., NEW YORK NY 10003
Mark Tabak director, officer: Chief Executive Officer 115 FIFTH AVENUE, NEW YORK NY 10003
Michael K. Attal director 425 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
James M Head officer: EVP & Chief Financial Officer 3001 COLORADO BLVD, DENTON TX 76210
Julie D Klapstein director 1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
C Martin Harris director
H&f Corporate Investors Viii, Ltd. 10 percent owner 415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
Music Investments Gp, Llc 10 percent owner C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Music Investments, L.p. 10 percent owner C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Glenn R August director C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Paul Galant officer: President, New Markets 88 WEST PLUMERIA DRIVE, SAN JOSE CA 95134
Michael Stuart Klein director, 10 percent owner, officer: Chief Executive Officer C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017